The microbial contaminant risk in Camber’s atovaquone oral suspension, USP 750 milligrams per 5 milliliters, can lead to “life-threatening infections such as endocarditis and necrotizing soft tissue infections,” the FDA said. No adverse reactions have been reported as of March 31.
The contaminant usually causes food poisoning, according to Cleveland Clinic.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
